Literature DB >> 34854780

Bacterial Keratitis: Similar Bacterial and Clinical Outcomes in Female versus Male New Zealand White Rabbits Infected with Serratia marcescens.

Eric G Romanowski1, Sanya Yadav1, Nicholas A Stella1, Kathleen A Yates1, John E Romanowski1, Deepinder K Dhaliwal1, Robert M Q Shanks1.   

Abstract

PURPOSE: Females and males respond differently to a number of systemic viral infections. Differences between females and males with respect to the severity of keratitis caused by Gram-negative bacteria such as Serratia marcescens are less well established.
METHODS: In this study, we injected female and male New Zealand White rabbit corneas with a keratitis isolate of S. marcescens and evaluated the eyes after 48 hours for a number of clinical and microbiological parameters.
RESULTS: No statistical differences in bacterial burden and corneal scores were recorded between female and male rabbits although there was a non-significant trend toward a higher frequency of female rabbits demonstrating hypopyons.
CONCLUSIONS: This data suggests that for experimental bacterial keratitis studies involving Gram-negative rods, a single sex or mixed group of rabbit is sufficient for evaluating pathology and bacterial burdens. This will reduce the number of animals used for subsequent studies.

Entities:  

Keywords:  Keratitis; Serratia marcescens; bacteria; female; male; microbial keratitis

Mesh:

Year:  2021        PMID: 34854780      PMCID: PMC9156527          DOI: 10.1080/02713683.2021.2013897

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.555


  31 in total

1.  Corneal rings with gram-negative bacteria.

Authors:  B J Mondino; B S Rabin; E Kessler; J Gallo; S I Brown
Journal:  Arch Ophthalmol       Date:  1977-12

Review 2.  Sex differences in prophylaxis and therapeutic treatments for viral diseases.

Authors:  Sabra L Klein
Journal:  Handb Exp Pharmacol       Date:  2012

3.  Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice.

Authors:  X Han; P Lundberg; B Tanamachi; H Openshaw; J Longmate; E Cantin
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  A quantitative rabbit model of vaccinia keratitis.

Authors:  Sharon Altmann; Andrew Emanuel; Megan Toomey; Kim McIntyre; Jill Covert; Richard Redd Dubielzig; Gary Leatherberry; Christopher J Murphy; Shantha Kodihalli; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

5.  Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases.

Authors:  Sabra L Klein
Journal:  Bioessays       Date:  2012-09-26       Impact factor: 4.345

Review 6.  Sex differences in animal models of psychiatric disorders.

Authors:  N Kokras; C Dalla
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

7.  Seasonal Variation in the Incidence of Late-onset Bleb-related Infection After Filtering Surgery in Japan: The Japan Glaucoma Society Survey of Bleb-related Infection Report 3.

Authors:  Hideto Sagara; Tetsuya Yamamoto; Tetsuju Sekiryu; Masashi Ogasawara; Toshiro Tango
Journal:  J Glaucoma       Date:  2016-01       Impact factor: 2.503

8.  The Rcs Stress Response System Regulator GumB Modulates Serratia marcescens-Induced Inflammation and Bacterial Proliferation in a Rabbit Keratitis Model and Cytotoxicity In Vitro.

Authors:  Eric G Romanowski; Nicholas A Stella; John E Romanowski; Kathleen A Yates; Deepinder K Dhaliwal; Anthony J St Leger; Robert M Q Shanks
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

9.  Microbial Keratitis at an Urban Public Hospital: A 10-Year Update.

Authors:  David T Truong; Minh-Thuy Bui; Pauras Memon; H Dwight Cavanagh
Journal:  J Clin Exp Ophthalmol       Date:  2015-11-30

10.  Transcription Factor EepR Is Required for Serratia marcescens Host Proinflammatory Response by Corneal Epithelial Cells.

Authors:  Kimberly M Brothers; Stephen A K Harvey; Robert M Q Shanks
Journal:  Antibiotics (Basel)       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.